- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Stroke Research and Treatment
Volume 2013 (2013), Article ID 560305, 7 pages
CSF and Serum Biomarkers Focusing on Cerebral Vasospasm and Ischemia after Subarachnoid Hemorrhage
1Department of Neurosurgery, Johann-Wolfgang Goethe University, 60528 Frankfurt, Germany
2Department of Neurosurgery, Ruprecht-Karls University of Heidelberg, 65120 Heidelberg, Germany
Received 17 November 2012; Revised 2 January 2013; Accepted 2 January 2013
Academic Editor: Fatima A. Sehba
Copyright © 2013 Carla S. Jung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- F. A. Sehba and J. B. Bederson, “Mechanisms of acute brain injury after subarachnoid hemorrhage,” Neurological Research, vol. 28, no. 4, pp. 381–398, 2006.
- V. L. Roger, A. S. Go, D. M. Lloyd-Jones, et al., “Heart disease and stroke statistics-2011 update: a report from the American Heart Association,” Circulation, vol. 123, no. 4, pp. e18–e209, 2011.
- N. F. Kassell, T. Sasaki, A. R. T. Colohan, and G. Nazar, “Cerebral vasospasm following aneurysmal subarachnoid hemorrhage,” Stroke, vol. 16, no. 4, pp. 562–572, 1985.
- F. A. Sehba, R. M. Pluta, and J. H. Zhang, “Metamorphosis of subarachnoid hemorrhage research: From delayed vasospasm to early brain injury,” Molecular Neurobiology, vol. 43, no. 1, pp. 27–40, 2011.
- S. Fergusen and R. L. Macdonald, “Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage,” Neurosurgery, vol. 60, no. 4, pp. 658–667, 2007.
- C. M. Fisher, G. H. Roberson, and R. G. Ojemann, “Cerebral vasospasm with ruptured saccular aneurysm–the clinical manifestations.,” Neurosurgery, vol. 1, no. 3, pp. 245–248, 1977.
- A. A. Rabinstein, J. A. Friedman, S. D. Weigand et al., “Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage,” Stroke, vol. 35, no. 8, pp. 1862–1866, 2004.
- B. Weir, M. Grace, J. Hansen, and C. Rothberg, “Time course of vasospasm in man,” Journal of Neurosurgery, vol. 48, no. 2, pp. 173–178, 1978.
- A. Kramer and J. Fletcher, “Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: a meta-analysis,” Stroke, vol. 40, no. 10, pp. 3403–3406, 2009.
- S. P. Lad, H. Hegen, G. Gupta, F. Deisenhammer, and G. K. Steinberg, “Proteomic biomarker discovery in cerebrospinal fluid for cerebral vasospasm following subarachnoid hemorrhage,” Journal of Stroke and Cerebrovascular Diseases, vol. 21, no. 1, pp. 30–41, 2012.
- M. M. Tisdall and M. Smith, “Cerebral microdialysis: Research technique or clinical tool,” British Journal of Anaesthesia, vol. 97, no. 1, pp. 18–25, 2006.
- A. Sarrafzadeh, D. Huax, O. Sakowtz et al., “Acute focal neurological deficits in aneurysmal subarachnoid hemorrhage: Relation of clinical course, CT findings, and metabolite abnormalities monitored with bedside microdialysis,” Stroke, vol. 34, no. 6, pp. 1382–1388, 2003.
- C. M. Fisher, J. P. Kistler, and J. M. Davis, “Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning,” Neurosurgery, vol. 6, no. 1, pp. 1–9, 1980.
- C. S. Jung, B. A. Iuliano, J. Harvey-White, M. G. Espey, E. H. Oldfield, and R. M. Pluta, “Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 101, no. 5, pp. 836–842, 2004.
- W. E. Hunt and R. M. Hess, “Surgical risk as related to time of intervention in the repair of intracranial aneurysms.,” Journal of Neurosurgery, vol. 28, no. 1, pp. 14–20, 1968.
- G. M. Teasdale, C. G. Drake, W. Hunt et al., “A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies.,” Journal of Neurology Neurosurgery and Psychiatry, vol. 51, no. 11, p. 1457, 1988.
- B. Jennett and M. Bond, “Assessment of outcome after severe brain damage. A practical scale,” Lancet, vol. 1, no. 7905, pp. 480–484, 1975.
- C. S. Jung, E. H. Oldfield, J. Harvey-White et al., “Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage,” Journal of Neurosurgery, vol. 107, no. 5, pp. 945–950, 2007.
- G. Crisi, A. Colombo, and M. De Santis, “CT and cerebral ischemic infarcts. Correlations between morphological and clinical-prognostic findings,” Neuroradiology, vol. 26, no. 2, pp. 101–105, 1984.
- M. Herrmann, P. Vos, M. T. Wunderlich, C. H. M. M. De Bruijn, and K. J. B. Lamers, “Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein,” Stroke, vol. 31, no. 11, pp. 2670–2677, 2000.
- M. Oertel, U. Schumacher, D. L. McArthur, S. Kästner, and D. K. Böker, “S-100B and NSE: markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome,” Journal of Clinical Neuroscience, vol. 13, no. 8, pp. 834–840, 2006.
- N. Weiss, P. Sanchez-Peña, S. Roche et al., “Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage,” Anesthesiology, vol. 104, no. 4, pp. 658–666, 2006.
- P. Sanchez-Peña, A. R. Pereira, N. A. Sourour et al., “S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage,” Critical Care Medicine, vol. 36, no. 8, pp. 2267–2273, 2008.
- S. Moritz, J. Warnat, S. Bele, B. M. Graf, and C. Woertgen, “The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage,” Journal of Neurosurgical Anesthesiology, vol. 22, no. 1, pp. 21–31, 2010.
- R. L. Macdonald, R. T. Higashida, E. Keller et al., “Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2),” The Lancet Neurology, vol. 10, no. 7, pp. 618–625, 2011.
- R. L. MacDonald, N. F. Kassell, S. Mayer et al., “Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial,” Stroke, vol. 39, no. 11, pp. 3015–3021, 2008.
- M. D. I. Vergouwen, D. Ilodigwe, and R. L. MacDonald, “Cerebral infarction after subarachnoid hemorrhage contributes to poor outcome by vasospasm-dependent and -independent effects,” Stroke, vol. 42, no. 4, pp. 924–929, 2011.
- J. P. Dreier, J. Kleeberg, M. Alam et al., “Endothelin-1-induced spreading depression in rats is associated with a microarea of selective neuronal necrosis,” Experimental Biology and Medicine, vol. 232, no. 2, pp. 204–213, 2007.
- J. P. Dreier, K. Körner, N. Ebert et al., “Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space,” Journal of Cerebral Blood Flow and Metabolism, vol. 18, no. 9, pp. 978–990, 1998.
- J. Kleeberg, G. C. Petzold, S. Major, U. Dirnagl, and J. P. Dreier, “ET-1 induces cortical spreading depression via activation of the ET A receptor/phospholipase C pathway in vivo,” American Journal of Physiology, vol. 286, no. 4, pp. H1339–H1346, 2004.
- J. D. Jordan and P. Nyquist, “Biomarkers and Vasospasm After Aneurysmal Subarachnoid Hemorrhage,” Neurosurgery Clinics of North America, vol. 21, no. 2, pp. 381–391, 2010.
- R. Bullock, A. Zauner, J. J. Woodward et al., “Factors affecting excitatory amino acid release following severe human head injury,” Journal of Neurosurgery, vol. 89, no. 4, pp. 507–518, 1998.
- N. Shimada, R. Graf, G. Rosner, and W. D. Heiss, “Ischemia-induced accumulation of extracellular amino acids in cerebral cortex, white matter, and cerebrospinal fluid,” Journal of Neurochemistry, vol. 60, no. 1, pp. 66–71, 1993.
- Z. Hong, Z. Xinding, Z. Tianlin, and C. Liren, “Excitatory amino acids in cerebrospinal fluid of patients with acute head injuries,” Clinical Chemistry, vol. 47, no. 8, pp. 1458–1462, 2001.
- B. Alessandri, E. Doppenberg, R. Bullock et al., “Glucose and lactate metabolism after severe human head injury: Influence of excitatory neurotransmitters and injury type,” Acta Neurochirurgica, Supplement, vol. 1999, no. 75, pp. 21–24, 1999.
- K. Hashimoto, G. Engberg, E. Shimizu, C. Nordin, L. H. Lindström, and M. Iyo, “Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients,” BMC Psychiatry, vol. 5, article 6, 2005.
- P. J. Hutchinson, M. T. O'Connell, P. G. Al-Rawi et al., “Increases in GABA concentrations during cerebral ischaemia: a microdialysis study of extracellular amino acids,” Journal of Neurology Neurosurgery and Psychiatry, vol. 72, no. 1, pp. 99–105, 2002.
- K. Campbell, P. Kalen, C. Lundberg, K. Wictorin, E. Rosengren, and A. Bjorklund, “Extracellular γ-aminobutyric acid levels in the rat caudate-putamen: monitoring the neuronal and glial contribution by intracerebral microdialysis,” Brain Research, vol. 614, no. 1-2, pp. 241–250, 1993.
- K. L. Drew, E. A. Pehek, B. T. Rasley, Y. L. Ma, and T. K. Green, “Sampling glutamate and GABA with microdialysis: Suggestions on how to get the dialysis membrane closer to the synapse,” Journal of Neuroscience Methods, vol. 140, no. 1-2, pp. 127–131, 2004.
- P. M. Hardy, “The protein amino acids,” in Chemistry and Biochemistry of the Amino Acids, G. C. Barrett, Ed., Chapman and Hall, 1985.
- M. M. Fadel, P. L. Foley, N. F. Kassell, and K. S. Lee, “Histidine attenuates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage,” Surgical Neurology, vol. 43, no. 1, pp. 52–58, 1995.
- S. P. Butcher, R. Bullock, D. I. Graham, and J. McCulloch, “Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion,” Stroke, vol. 21, no. 12, pp. 1727–1733, 1990.
- H. Naritomi, M. Sasaki, M. Kanashiro, M. Kitani, and T. Sawada, “Flow thresholds for cerebral energy disturbance and Na+ pump failure as studied by in vivo 31P and 32Na nuclear magnetic resonance spectroscopy,” Journal of Cerebral Blood Flow and Metabolism, vol. 8, no. 1, pp. 16–23, 1988.
- J. Drejer, H. Benveniste, N. H. Diemer, and A. Schousboe, “Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro,” Journal of Neurochemistry, vol. 45, no. 1, pp. 145–151, 1985.
- J. Sanchez-Prieto and P. Gonzalez, “Occurrence of a large Ca2+-independent release of glutamate during anoxia in isolated nerve terminals (synaptosomes),” Journal of Neurochemistry, vol. 50, no. 4, pp. 1322–1324, 1988.